We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$96.1M
AUM Growth
+$70.2M
Cap. Flow
+$68.2M
Cap. Flow %
70.96%
Top 10 Hldgs %
98.45%
Holding
27
New
16
Increased
–
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
TSHA icon
Taysha Gene Therapies
TSHA
+$47M
2
CSTL icon
Castle Biosciences
CSTL
+$10.9M
3
IMTX icon
Immatics
IMTX
+$7.35M
4
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
+$2.49M
5
CHRS icon
Coherus Oncology
CHRS
+$763K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$853K
2
SYK icon
Stryker
SYK
+$685K
3
XYZ
Block Inc
XYZ
+$52K
4
VT icon
Vanguard Total World Stock ETF
VT
+$4.17K

Sector Composition

Rank Sector Weight
1 Healthcare 79.34%
2 Technology 4.85%
3 Consumer Discretionary 0.15%
4 Communication Services 0.1%
5 Utilities 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYK icon
26
Stryker
SYK
$133B
– –
-3,800
Closed -$685K
XYZ
27
Block Inc
XYZ
$48.4B
– –
-500
Closed -$52K
1
2

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q3 2020 Portfolio in Review

As of Q3 2020, University of Texas/Texas AM Investment Management Co (UTIMCO) held 27 positions worth $96.1M, up 271% from $25.9M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $68.2M of net new capital in Q3 2020, opening 16 new positions. Its largest new stake was Taysha Gene Therapies: 2,000,000 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Total World Stock ETF, an estimated $4.17K trimmed.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q3 2020 buy was Taysha Gene Therapies: 2,000,000 shares worth $44.8M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q3 2020 reduction was Vanguard Total World Stock ETF, cutting an estimated $4.17K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Amgen in Q3 2020, selling an estimated $853K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 98% of its $96.1M portfolio in Q3 2020.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 16 new positions and closed 3 in Q3 2020.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 271% quarter-over-quarter to $96.1M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q3 2020, filed 6 Nov 2020.